Enhancement of nitric oxide synthesis by L-arginine supplementation in renal disease: Is it good or bad?

Mineral and Electrolyte Metabolism

Volumn 23, Issue 3-6, 1997, Pages 144-150

  De Nicola, Luca ^a   Minutolo, Roberto ^a   Bellizzi, Vincenzo ^a   Andreucci, Michele ^a   Verde, Antonietta La ^a   Cianciaruso, Bruno ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiotensin II; Arginine; Chronic renal failure; Cyclosporine; Glomerulonephritis; Hypertension; Nitrates; Nitric oxide; Nitrites; Renal function

Indexed keywords

ARGININE; NITRIC OXIDE;

CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; PRIORITY JOURNAL;

ANIMALS; ARGININE; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY DISEASES; NITRIC OXIDE; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0030707796     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (83)

1. Barbul A: Arginine: Biochemistry, physiology and therapeutic implications. J Parent Enter Nutr 1986;10:227-238.
2. Levillain O, Hus-Citharel A, Morel F, Bankir L: Localization of arginine synthesis along rat nephron. Am J Physiol 1990;259:F916-F923.
3. Harper A, Yoshimura NN: Protein quality, amino acid balance, utilization and evaluation of diets containing amino acids as therapeutic agents. Nutrition 1993;9:46-469.
4. Featherstone WR, Rogers QR, Freedland RA: Relative importance of kidney and liver in synthesis of arginine by the rat. Am J Physiol 1973;224:127-129.
5. Gopalakrishna R, Nagarajan B: Effect of growth and differentiation on distribution of arginase and arginine in rat tissue. Indian J Biochem Biophys 1979;16:66-68.
6. Rose WC: The nutritive significance of the amino acids and certain related compounds. Science 1937;86:298-300.
7. Castillo L, Chapman TE, Sanchez M, Yu YM, Burke JF, Ajami AM, Vogt J, Young VR: Plasma arginine and citrulline kinetics in adult given adequate and arginine-free diets. Proc Natl Acad Sci USA 1993;90:7749-7753.
8. Kuhlmann MK, Kopple JD: Amino acid metabolism in the kidney. Semin Nephrol 1990;10:445-457.
9. Tizianello A, De Ferrari G, Garibotto G, Guerreri G, Robaudo C: Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 1980;65:1162-1173.
10. Barbul A, Sisto DA, Wasserkrug HL: Arginine stimulates lymphocyte immune response in healthy humans. Surgery 1981;90:244-251.
11. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1988;327: 524-526.
12. Marietta MA: Nitric oxide synthase structure and mechanism. J Biol Chem 1993;268:12231-12234.
13. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;27:2002-2012.
14. Ketteler M, Border WA, Noble N: Cytokines and L-arginine in renal injury and repair. Am J Physiol 1994;267:F197-F207.
15. Nicholson AG, Haites NE, McKay NG, Wilson HM, MacLeod AM, Benjamin N: Induction of nitric oxide synthase in human mesangial cells. Biochem Biophys Res Commun 1993;193:1269-1274.
16. Bosse HM, Moser D, Bachmann S: Constitutive isoforms of nitric oxide synthase (NOS) in the kidney: Localisation in various mammalian species including man. J Am Soc Nephrol 1994;5:574.
17. McLay JS, Chatterjee P, Nicolson G, Jardine AJ, McLay NG, Ralston SH, Grabowski P, Haites NE, MacLeod AM, Hawksworth GM: Nitric oxide production by human proximal tubular cells: A novel immunomodulatory mechanism? Kidney Int 1994;46:1043-1049.
18. Reyes AA, Karl IE, Klahr S: Role of arginine in health and in renal disease. Am J Physiol 1994;267:F331-F346.
19. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-1172.
20. Corso G, De Nicola L, Cianciaruso B, Dello Russo A, Napoli C, Bellizzi V: Automated enzymatic determination of urinary nitrates in humans. Curr Ther Res 1996;57:878-884.
21. Raji L, Baylis C: Glomerular actions of nitric oxide. Kidney Int 1995;48:20-32.
22. Zatz R, De Nucci G: Effect of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 1991;261:F360-F363.
23. De Nicola L, Blantz RC, Gabbai FB: Nitric oxide and angiotensin II: Glomerular and tubular interaction in the rat. J Clin Invest 1992;89:1248-1256.
24. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon glomerular microcirculation and ultrafiltration coefficient in the rat. J Clin Invest 1976;57:419-434.
25. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992;90:278-281.
26. Qiu C, Engels K, Baylis C: Endothelin modulates the presser actions of acute systemic nitric oxide blockade. J Am Soc Nephrol 1995;6:1476-1481.
27. 2-Adrenoceptors determine the response to nitric oxide inhibition in the rat glomerulus and proximal tubule. J Am Soc Nephrol 1995;6:1482-1490.
28. Braam B, Koomans HA: Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int 1995;48:1406-1411.
29. Edwards RM, Trizna W: Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors. J Am Soc Nephrol 1993;4:1127-1132.
30. Salazar JF, Alberola A, Nakamura T, Granger JP: Role of nitric oxide in the renal hemodynamic response to a meat meal. Am J Physiol 1994;267: R1050-R1055.
31. Danielson LA, Conrad KP: Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 1995;96: 482-490.
32. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8 bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
33. Garg UC, Hassid A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989;257:F60-F66.
34. Garg UC, Hassid A: Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/c3T3 fibroblasts by a cGMP independent mechanism. Biochem Biophys Res Commun 1990;171:474-479.
35. Schultz PJ, Raji L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992;90:1718-1725.
36. Raij L: Glomerular thrombosis in pregnancy: Role of L-arginine and nitric oxide pathway. Kidney Int 1994;45:775-781.
37. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FR: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993;92:1859-1865.
38. Amore A, Gianoglio B, Ghigo D, Peruzzi L, Porcel-lini MG, Bussolino F, Costamagna C, Cacace G, Picciotto G, Mazzucco G, Sena LM, Coppo R: A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995;47:1507-1514.
39. Reyes AA, Karl IE, Kissane J, Klahr S: L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 1993;4:1039-1045.
40. Mathis KM, Banks RO: Role of nitric oxide and angiotensin II in diabetes mellitus-induced glomerular hyperfiltration. J Am Soc Nephrol 1996;7: 105-112.
41. Chen PY, St John PL, Abrahamson DR, Sanders PW: Chronic arginine supplementation prevents hypertensive nephrosclerosis and hypertension in Dahl/Rapp salt-sensitive (SS/Jr) rats. Clin Res 1992;40:353.
42. Ono H, Ono Y, Froloich ED: ACE inhibition prevents and reverses L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats. Hypertension 1996;27:176-183.
43. Tolins JP, Shultz PJ: Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994;46:230-236.
44. Schramm L, Heidbreder E, Lopau K, Schaar J, De Cicco D, Götz R, Heidland A: Toxic acute renal failure in the rat: Effects of L-arginine and N-methyl-L-arginine on renal function. Nephrol Dial Transplant 1994;9(suppl4):88-93.
45. Reyes AA, Martin D, Settle S, Klahr S: EDRF role in renal function and blood pressure of normal rats and rats with obstructive nephropathy. Kidney Int 1992;41:403-413.
46. Reyes AA, Porras BH, Chasalow F, Klahr S: Administration of L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin induced nephrosis. Kidney Int 1994;45:1346-1354.
47. Katoh T, Takahashi K, Klahr S, Reyes AA, Badr KF: Dietary supplementation with L-arginine ameliorates glomerular hypertension in rats with subtotal nephrectomy. J Am Soc Nephrol 1994;4: 1690-1694.
48. Fujihara CK, De Nucci G, Zatz R: Chronic nitric oxide synthase inhibition aggravates glomerular injury in rats with subtotal nephrectomy. J Am Soc Nephrol 1995;5:1498-1507.
49. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
50. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwanz D, Cabili S, Silverberg D, laina A: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-1521.
51. Ferrario R, Takahashi K, Fogo A, Badr K, Munger KA: Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J Am Soc Nephrol 1994;4:1847-1854.
52. Waddington S, Cook TH, Reaveley D, Jansen A, Cattell V: L-Arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 1996;49:1090-1096.
53. Narita I, Border WA, Ketteler M, Rouslahti E, Noble NA: L-Arginine may mediate the therapeutic effects of low protein diet. Proc Natl Acad Sci USA 1995;92:4552-4556.
54. Narita I, Border WA, Ketteler M, Noble NA: Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis. Lab Invest 1995;72:17-24.
55. Gmonomethyl-L-arginine. J Exp Med 1994;179:651-660.
56. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA: Apparent hydroxyl radical production by peroxynitrite: Implication for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 1990;87:1223-1227.
57. Jansen A, Cook TH, Taylor MG, Largen P, Riveros-Moreno V, Moncada S, Cattell V: Induction of nitric oxide synthase in rat immune complex glomerulonephritis. Kidney Int 1994;45:1215-1219.
58. Cook TH, Jansen A, Lewis S, Largen P, O'Donnell M, Reaveley D, Cattell V: Arginine metabolism in experimental glomerulonephritis: Interaction between nitric oxide synthase and arginase. Am J Physiol 1994;267:F646-F653.
59. Schulze-Lohoff E, Brand K, Fees H, Netzker R, Sterzel RB: Role of ornithine decarboxylase for proliferation of mesangial cells in culture. Kidney Int 1991;40:684-690.
60. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-4655.
61. Schultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 1990;258:F162-F167.
62. Vallance P, Collier J, Moncada S: Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;ii:997-1000.
63. Vallance P, Collier J, Moncada S: Nitric oxide synthesised from L-arginine mediates endothelium-dependent dilatation in human veins in vivo. Cardiovasc Res 1989;23:1053-1057.
64. Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, Malinski T: Direct measurement of nitric oxide in human beings. Lancet 1995;345:153-154.
65. Haynes WG, Noon JP, Walker BR, Webb DJ: L-NMMA increases blood pressure in man. Lancet 1993;342:931-932.
66. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kalo R: L-Arginine-induced hypotension. Lancet 1990;336:696.
67. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo F: L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992;19:619-625.
68. G-monomethyl-L-argmine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal. J Hypertens 1992;10:1025-1031.
69. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993;87:1468-1474.
70. G-monomethyl-L-arginine (L-NMMA) on forearm blood flow (FBF) in treated hypertensive patients. Br J Clin Pharmacol 1992;35:68P.
71. Panza JA, Casino PR, Badar DM, Quyyumi AA: Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension. Circulation 1993;87:1475-1481.
72. Tajiri K, Miyakawa H, Izumi N, Marumo F, Sato C: Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascite: Role of nitric oxide. Hepatology 1995;22:1430-1435.
73. Vallance P, Leone A, Calver A, Collier J, Moncada S: Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-575.
74. MacAllister RJ, Whitley GS, Vallance P: Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 1994;45:737-742.
75. G dimethylarginine by human endothelial cells. Endothelium 1993;1:137-140.
76. Noris M, Benigni A, Boccard P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993;44:445-450.
77. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 1995;123:35-37.
78. Yui Y, Hattori R, Kosuga K, Eizawa H, Hiki K, Kawai C: Purification of nitric oxide synthase from rat macrophages. J Biol Chem 1991;266:12544-12547.
79. Arese M, Strasly M, Ruva C, Costamagna C, Ghigo D, MacAllister R, Verzetti G, Tetta C, Bosia A, Bussolino F: Regulation of nitric oxide synthesis in uremia. Nephrol Dial Transplant 1995;10:1386-1397.
80. Wolf SC, Erley CM, Kenner S, Berger ED, Risler T: Does L-arginine alter proteinuria and renal hemodynamics in patients with chronic glomerulonephritis and hypertension? Clin Nephrol 1995;43: S42-S46.
81. Claris-Appiani A, Ardissimo G, Coppo R, Bonaudo R, Daccò V, Bettinelli A, Tirelli A: Effect on renal function of arginine supplementation in children with chronic renal insufficiency (abstract). J Am Soc Nephrol 1993;4:766.
82. Cianciaruso B, Bellizzi V, Minutolo R, Andreucci M, Russo R, Conte G, De Nicola L: Chronic supplementation of L-arginine in patients with moderate renal failure secondary to chronic glomerulonephritis (abstract). J Am Soc Nephrol 1996;7:1616.
83. Maschio G, Alberti D, Janin G, Locatelli F, Mann JFE, Motolese M, Ponticelli C, Ritz E, Zucchelli P: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-945.